Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 22;62(22):e202218000.
doi: 10.1002/anie.202218000. Epub 2023 Mar 15.

Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems

Affiliations
Review

Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems

Guillermo Moreno-Alcántar et al. Angew Chem Int Ed Engl. .

Abstract

The discovery of the medicinal properties of gold complexes has fuelled the design and synthesis of new anticancer metallodrugs, which have received special attention due to their unique modes of action. Current research in the development of gold compounds with therapeutic properties is predominantly focused on the molecular design of drug leads with superior pharmacological activities, e.g., by introducing targeting features. Moreover, intensive research aims at improving the physicochemical properties of gold compounds, such as chemical stability and solubility in the physiological environment. In this regard, the encapsulation of gold compounds in nanocarriers or their chemical grafting onto targeted delivery vectors could lead to new nanomedicines that eventually reach clinical applications. Herein, we provide an overview of the state-of-the-art progress of gold anticancer compounds, andmore importantly we thoroughly revise the development of nanoparticle-based delivery systems for gold chemotherapeutics.

Keywords: Anticancer; Gold Compounds; Nano-Formulation; Nanomedicine; Nanoparticles.

PubMed Disclaimer

Similar articles

Cited by

References

    1. H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, CA Cancer J. Clin. 2021, 71, 209-249.
    1. S. Reardon, Science 2011, 333, 558-559.
    1. S. Pilleron, D. Sarfati, M. Janssen-Heijnen, J. Vignat, J. Ferlay, F. Bray, I. Soerjomataram, Int. J. Cancer 2019, 144, 49-58.
    1. World Health Organization, WHO, WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All., World Health Organization, Geneva, 2020.
    1. B. Rosenberg, Interdiscip. Sci. Rev. 1978, 3, 134-147.

Publication types

LinkOut - more resources